Historical position

Jim Chanos’s Johnson & Johnson (JNJ) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Kynikos Associates LPVerified through Q3 2023
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2016Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares49.84KHighest verified quarter-end share count
Quarters reported3Verified quarters with shares above zero
What happened?

Kynikos Associates LP first reported Johnson & Johnson in Q1 2016. The reported position was increased and reduced across later filings. Verified positive position history runs through Q3 2016. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2016
Sold the entire position−35.39K shares · No shares reported at quarter-end
Q3 2016
Sold 29.0% of the position−14.46K shares · 35.39K shares remained
Filing context

Quarter-end price $118.12 · Estimated holding basis $113.49

Q2 2016
Bought 67.7% more+20.11K shares · 49.84K shares reported after the change
Filing context

Quarter-end price $121.30 · Estimated holding basis $113.49

Q1 2016
New position+29.73K shares · 29.73K shares reported
Filing context

Quarter-end price $108.21 · Estimated holding basis $108.21

Portfolio importance

How important was Johnson & Johnson in Kynikos Associates LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight1.4%Q3 2016
Last reported rank#16of 32 reported positions
Peak portfolio weight1.9%Q2 2016
Best historical rank#10Q2 2016
At peak importanceQ2 2016
JNJ
1.9%
Largest holding
15.9%
Cross-investor discovery

Who else owns Johnson & Johnson?

Also reported by 5 other tracked investors in their latest verified filings.

Ray DalioBridgewater Associates, LP
JNJ0.7% of reported portfolio
Joel GreenblattGotham Asset Management
JNJ0.1% of reported portfolio
George SorosSoros Fund Management
JNJ0.1% of reported portfolio
Explore Johnson & Johnson across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$269.992026-09-18

Market context only; not an investor transaction price.

Latest verified investor filingQ3 2023 · filed 2023-11-14
Open SEC filing ↗

View Johnson & Johnson stock page →

Kynikos Associates LP is the filer’s former SEC name; the current SEC identity is Chanos & Co LP (CIK 0001446440). Its last located Form 13F covers Sep 30, 2023. No later 13F appears in the verified five-year SEC window through Jun 30, 2026, so this is a historical disclosure snapshot—not a claim about current positions. Options are shown separately.